Safety and Efficacy Study of Human Umbilical Cord Mesenchymal Stem Cells in Preventing Arteriovenous Fistula Stenosis in Patients With End-Stage Diabetic Kidney Disease
Clinical trial NCT07452822 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07452822
- Sponsor
- Jiangsu Topcel-KH Pharmaceutical Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-20
- Primary completion
- 2027-03-30
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.